What Are the Key Medical Device Quality Standards? ISO 13485, MDR, FDA & UKCA
September 2026
If you’re choosing a contract manufacturer for a medical device, the conversation usually comes back to one question, “what standards do you work to?”
It’s not a box-ticking question. Understanding the medical device quality standards a manufacturer holds, and how consistently they apply them day to day, says a great deal about whether your device will reach the market smoothly or gets held up in a compliance queue for months. This guide brings the key quality standards together in one place – what they are, who they’re for, and why they matter more than the certification itself might suggest.
ISO 13485: what is it, and why does it matter?
ISO 13485 is the international standard for a medical device quality management system, and it’s the baseline any serious manufacturer in this industry needs to meet.
It covers the full device lifecycle, from design controls, risk management, supplier evaluation and traceability to corrective and preventive action. The value isn’t the documentation it produces, though. It’s the discipline it enforces, every process is defined, every change is controlled, and every issue is investigated. That discipline is what prevents small manufacturing errors from becoming device failures.
We’ve held ISO 13485 for 29 years, and it underpins how our cleanroom operates, how our moulding processes are validated, and how every batch is documented from raw material through to dispatch. It’s also the standard most other regulatory frameworks now build on, which brings us to the next one.
EU MDR classification requirements: higher scrutiny, more evidence
The EU Medical Device Regulation (MDR) is the rulebook that decides whether a device can legally be sold in the EU. It replaced an older set of rules, and the change was a big one for a lot of manufacturers.
Under the old rules, many devices were treated as lower risk. Under MDR classification requirements, the same devices are often reclassified as higher risk. That means more work, more clinical evidence to prove the device is safe and effective, more technical documentation, and closer checks from the independent bodies (called Notified Bodies) who approve devices before they go to market.
This matters right from the design stage, not just when it’s time to certify the finished device. Early decisions, like what materials are used, what the device is for, and whether it’s reusable or single-use, all affect which risk category it falls into and how much evidence will be needed later. That’s why we prefer to talk this through with customers early on, rather than only getting involved once a design is already finished.
The deadlines for older devices to move across to the new MDR rules have also been pushed back more than once, with some now able to continue under the old system until the end of 2028. Because this varies by device type, it’s worth checking the specific deadline for your device rather than assuming one date applies to everything.
FDA: what’s changed for manufacturers selling into the US
If you’re looking to sell into the US market, this is an important one to understand right now. For decades, the FDA had its own set of quality rules, separate from the international ISO 13485 standard, and CE standards. Which meant manufacturers selling globally often had to run two different quality systems side by side, one for the US and one for everywhere else.
That changed on 2 February 2026, when the FDA introduced a new regulation, called the QMSR, which now uses ISO 13485 as its basis rather than running a separate system. In practice, this means a manufacturer that already has a strong ISO 13485 system in place is most of the way to meeting the FDA’s requirements too. It’s worth noting the two aren’t identical, as the FDA has added a small number of extra US-specific requirements on top, but the overlap is now much greater than before.
For OEMs planning to launch in the US, this is genuinely good news. One well-run quality system now does far more of the work than it used to, rather than needing two separate ones.
UKCA: the UK’s own approach, still taking shape
UKCA marking is the UK’s own version of a product safety mark, used since Brexit as the route to market for devices sold in Great Britain (England, Scotland and Wales). It sits alongside CE marking, which is still accepted too, for now.
Right now, in 2026, devices with a valid CE mark can still be sold in Great Britain under temporary arrangements. Depending on the type of device and which EU rules it was certified under, this generally continues until mid-2028 or mid-2030. UKCA is intended to be the UK’s long-term route once these temporary arrangements end.
This area has changed a fair amount over the past year and is still moving. The UK’s regulator, the MHRA, ran a consultation earlier in 2026 looking at extending how long CE-marked devices can continue to be accepted. A wider update to the UK’s medical device rules is also still being worked on, including new routes that would let manufacturers rely on approvals they’ve already received from the FDA, EU or other trusted regulators. If you’re planning to launch a device in Great Britain, it’s worth checking the latest MHRA guidance directly, since this has changed more than once.
Standards in practice, not just on paper
None of these standards exist in isolation, and none of them are just paperwork. They’re the reason a device manufactured to these requirements can be trusted in an operating theatre, a GP surgery, or a patient’s home. When we talk to OEMs about classification, documentation, or supplier audits, we’re not doing it because a standard says we must, we’re doing it because it’s how you build a device that works every time for the person relying on it.
If you’re weighing up manufacturing partners and want to talk through where your device sits against any of this, we’re always happy to have that conversation early, long before the design is locked down.
FAQ’s
Do all UK medical device manufacturers need ISO 13485?
It isn’t a legal requirement on its own, but in practice it’s the standard nearly every serious manufacturer holds, and many customers and regulators expect it. It also now forms the basis of both FDA and EU requirements, so holding it makes it far easier to sell into multiple markets.
What's the difference between CE marking and UKCA marking?
CE marking shows a device meets EU requirements, while UKCA marking shows it meets UK requirements for Great Britain. Since Brexit, both are currently accepted in Great Britain under transitional arrangements, though UKCA is intended to become the long-term route.
Has the FDA changed its quality system requirements?
Yes. As of 2 February 2026, the FDA introduced a new regulation called the QMSR, which is now based on the international ISO 13485 standard rather than a separate US only system. Manufacturers already meeting ISO 13485 are largely aligned with the new FDA requirements too.
Does EU MDR affect devices that were already CE marked?
It can. Some devices previously classified as lower risk under the old rules are being reclassified as higher risk under EU MDR, which brings extra requirements around clinical evidence and documentation. Deadlines for older devices to transition vary by device type, so it’s worth checking the specific timeline that applies.
Speak to a UK Medical Device Contract Manufacturing Expert
Contact us today to discuss how Meridian Medical can support your next medical device project. Get in touch by filling out our online form or contacting us at 01903 732344 or info@meridian-medical.com.
Author: Andrew Wootten, Quality and Regulatory Manager
Andrew Wootten has been at the forefront of Meridian Medical’s quality and regulatory functions for over a decade. With a career in quality management that began in 1989 and extensive experience in the medical device sector since 2002, Andrew is a seasoned expert. He holds a City and Guilds certificate in Quality Assurance, a diploma in Quality Management from BSI, and is a certified internal auditor for ISO 13485, ISO 9001, and ISO 14001. Andrew ensures our regulatory compliance and drives the company’s commitment to excellence in quality and safety, making him a trusted authority in the industry. His deep understanding of global regulatory challenges and unwavering dedication to quality assurance position him as a key figure in delivering safe, compliant and top-quality medical devices.
